Clinical phenotypes of COPD and their impact on quality of life: A cross-sectional study
Background: A Chronic Obstructive Pulmonary Disease (COPD) phenotype is a single or group of disease characteristics that describe differences between individuals based on clinically important factors such as symptoms,
exacerbations, morbidity, and treatment responses. Many studies estimated the prevalence of various phenotypes, but very few studies looked into their quality of life. We aimed to estimate the prevalence of different
COPD phenotypes and their disease-specific Health-Related Quality of Life (HRQoL).
Materials and methods: The prospective study, with a sample size of 136, was conducted between May 2021 and
December 2022 in a tertiary teaching institute. Based on their clinical features, COPD patients were classified
into 4 different clinical phenotypes, and their disease-specific quality of life was assessed using St. George
Respiratory Questionnaire-COPD(SGRQ-c) and COPD Assessment Test (CAT) questionnaires.
Results: Among 136 COPD patients, the frequency of Non-Exacerbator (NE), Exacerbator Emphysema (EEM),
Exacerbator Chronic Bronchitis (ECB), and Asthma COPD overlap (ACO) phenotypes was 79(58.1 %), 16(11.8
%), 31(22.8 %), and 10(7.4 %) respectively. Based on the SGRQ-c score, the ECB and EEM phenotypes had a
significantly poorer Quality of life (QoL) when compared with NE(P
exacerbations, morbidity, and treatment responses. Many studies estimated the prevalence of various phenotypes, but very few studies looked into their quality of life. We aimed to estimate the prevalence of different
COPD phenotypes and their disease-specific Health-Related Quality of Life (HRQoL).
Materials and methods: The prospective study, with a sample size of 136, was conducted between May 2021 and
December 2022 in a tertiary teaching institute. Based on their clinical features, COPD patients were classified
into 4 different clinical phenotypes, and their disease-specific quality of life was assessed using St. George
Respiratory Questionnaire-COPD(SGRQ-c) and COPD Assessment Test (CAT) questionnaires.
Results: Among 136 COPD patients, the frequency of Non-Exacerbator (NE), Exacerbator Emphysema (EEM),
Exacerbator Chronic Bronchitis (ECB), and Asthma COPD overlap (ACO) phenotypes was 79(58.1 %), 16(11.8
%), 31(22.8 %), and 10(7.4 %) respectively. Based on the SGRQ-c score, the ECB and EEM phenotypes had a
significantly poorer Quality of life (QoL) when compared with NE(P